Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Surgery
|
October 11, 2015
Editorial: Is molecular testing cost effective? It depends
Carrie C Lubitz
Annals of Surgical Oncology
|
April 25, 2012
Sestamibi-negative patients: to operate or image?
Carrie C Lubitz, Herbert Chen
Annals of Surgical Oncology
|
June 2, 2018
Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients
Rajshri M Gartland, Carrie C Lubitz
Surgery
|
November 19, 2016
Editorial: Complex decision making in thyroid cancer: Costs and consequences-is less more?
Susan C Pitt, Carrie C Lubitz
Advances in Surgery
|
October 28, 2005
The differentiation of benign and malignant thyroid nodules
Carrie C Lubitz, Thomas J Fahey
Annals of Surgical Oncology
|
October 27, 2018
Reply to "Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on the Outcomes of Lobectomy"
Rajshri M Gartland, Carrie C Lubitz
Cancer
|
August 13, 2016
The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients
Carrie C Lubitz, Julie A Sosa
Nature Clinical Practice. Endocrinology & Metabolism
|
September 8, 2006
Gene expression profiling of thyroid tumors--clinical applicability
Carrie C Lubitz, Thomas J Fahey
Gland Surgery
|
March 25, 2020
Primary aldosteronism
Sean M Wrenn, Anand Vaidya, Carrie C Lubitz
Annals of Surgical Oncology
|
March 23, 2021
ASO Author Reflections: Does Timely Surgery Matter in Papillary Thyroid Cancer?
Scott C Fligor, Carrie C Lubitz, Benjamin C James
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Surgery
|
October 11, 2015
Editorial: Is molecular testing cost effective? It depends
Carrie C Lubitz
Annals of Surgical Oncology
|
April 25, 2012
Sestamibi-negative patients: to operate or image?
Carrie C Lubitz, Herbert Chen
Annals of Surgical Oncology
|
June 2, 2018
Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients
Rajshri M Gartland, Carrie C Lubitz
Surgery
|
November 19, 2016
Editorial: Complex decision making in thyroid cancer: Costs and consequences-is less more?
Susan C Pitt, Carrie C Lubitz
Advances in Surgery
|
October 28, 2005
The differentiation of benign and malignant thyroid nodules
Carrie C Lubitz, Thomas J Fahey
Annals of Surgical Oncology
|
October 27, 2018
Reply to "Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on the Outcomes of Lobectomy"
Rajshri M Gartland, Carrie C Lubitz
Cancer
|
August 13, 2016
The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients
Carrie C Lubitz, Julie A Sosa
Nature Clinical Practice. Endocrinology & Metabolism
|
September 8, 2006
Gene expression profiling of thyroid tumors--clinical applicability
Carrie C Lubitz, Thomas J Fahey
Gland Surgery
|
March 25, 2020
Primary aldosteronism
Sean M Wrenn, Anand Vaidya, Carrie C Lubitz
Annals of Surgical Oncology
|
March 23, 2021
ASO Author Reflections: Does Timely Surgery Matter in Papillary Thyroid Cancer?
Scott C Fligor, Carrie C Lubitz, Benjamin C James
Page
of 7